Evidence map›Paper›PMID 42472307›Full record

ArticleNeuro-oncology advances

Brain invasion as a diagnostic histological feature of atypical meningiomas: Not a standalone diagnostic criterion.

Li Zhang, Lei Lou, Weiwei Fu, Long Wu, Xiaodan Fu, Sheng Zhang, Xingfu Wang

Abstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Li ZhangDepartment of Pathology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.ORCID https://orcid.org/0009-0002-5028-2328
Lei LouDepartment of Pathology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Weiwei FuDepartment of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Long WuDepartment of Pathology, Fujian Medical University Union Hospital, Fuzhou, China.
Xiaodan FuDepartment of Pathology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Sheng ZhangDepartment of Pathology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Xingfu WangDepartment of Pathology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.ORCID https://orcid.org/0000-0002-0734-4936

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: WHO classifies brain invasion as an independent criterion for atypical meningiomas, though its prognostic value remains debated. Methods: This study retrospectively analyzed 1,476 primary meningiomas diagnosed at the First Affiliated Hospital of Fujian Medical University (1997-2021) using Cox regression and Kaplan-Meier (K-M) analysis for recurrence and recurrence-free survival (RFS). Results: Brain-invasive otherwise benign (BIOB) meningiomas had lower recurrence rates than classical WHO grade 2 (cWHO2) ( Conclusion: These findings suggest that brain invasion alone is insufficient for diagnosing atypical meningiomas and should be considered alongside additional histological features for risk stratification.

Indexed as

atypical histological featureBIOBbrain invasionmeningiomaprognosis

Identifiers

PMID42472307
PMCPMC13379626

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.